Kronox Lab Sciences IPO (Kronox Lab Sciences Limited IPO)
Kronox Lab Sciences IPO open for bidding on 3rd June 2024, and ends on 5th June 2024.
Kronox Lab Sciences Limited, established in 2008, excels in producing high-purity specialty fine chemicals. With a portfolio of over 185 products, Kronox serves industries such as pharmaceuticals, scientific research, nutraceuticals, biotechnology, and agrochemicals.
Operating from three advanced manufacturing facilities in Gujarat, India, Kronox caters to clients in over 20 countries. These facilities are equipped with state-of-the-art technology, ensuring precision and consistency in production, meeting international standards. The company also offers custom manufacturing to meet specific client needs.
For more details refer to Kronox Lab Sciences IPO RHP
Kronox Lab IPO Details
| IPO Date | 3rd June 2024 to 5th June 2024 |
| Listing Date | 10th June 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹129 to ₹136 per share |
| Lot Size | 110 Shares |
| Total Issue Size | 95,70,000 shares (aggregating up to ₹130.15 Cr) |
| Offer for Sale | 95,70,000 shares of ₹10 (aggregating up to ₹130.15 Cr) |
| Issue Type | Book Built Issue IPO |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor | 28,71,000(30%) |
| QIB | 19,14,000(20%) |
| NII | 14,35,500(15%) |
| bNII | 9,57,000(10%) |
| sNII | 4,78,500(5%) |
| Retail | 33,49,500(35%) |
| Total | 95,70,000(100%) |
Kronox Lab IPO Timeline
| IPO Open | 3rd June 2024 |
| IPO Close | 5th June 2024 |
| Basis Of Allotment | 6th June 2024 |
| Initiation of Refunds | 7th June 2024 |
| Credit of Shares to Demat | 7th June 2024 |
| Listing Date | 10th June 2024 |
Fundamentals
Data as of 31st December 2023
| Market Cap | ₹504.61 Cr | P/E Ratio- Pre IPO | 30.37 |
| RoNW% | 25.66% | P/E Ratio- Post IPO | 24.47 |
| RoCE | 33.15% | P/B Ratio | 8.37 |
| Debt to Equity | 0 | PAT Margin% | 22.6% |
Kronox Lab IPO Objectives
Company proposes to utilise the Net Proceeds towards funding of the following objects:
- Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of our Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders as well as provide a public market for the Equity Shares in India.
